Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 21, 2010; 16(35): 4377-4393
Published online Sep 21, 2010. doi: 10.3748/wjg.v16.i35.4377
Published online Sep 21, 2010. doi: 10.3748/wjg.v16.i35.4377
Table 1 Michigan alcoholism prognosis scale
Criterion | Points |
Acceptance of alcoholism | |
Patient and family | 4 |
Patient only | 3 |
Family only | 2 |
Neither | 1 |
Prognostic indices | |
Substitute activities | Yes 3, No 1 |
Behavioral consequences | Yes 3, No 1 |
Hope/self-esteem | Yes 3, No 1 |
Social relationship | Yes 3, No 1 |
Social stability | |
Steady job | 1 |
Stable residence | 1 |
Does not live alone | 1 |
Stable marriage | 1 |
Rating | /201 |
Table 2 High-risk alcoholism relapse scale
Item | Score |
Duration of heavy drinking (yr) | |
≤ 11 | 0 |
11-25 | 1 |
≥ 25 | 2 |
Daily drinks1 (n) | |
≤ 9 | 0 |
9-17 | 1 |
≥ 17 | 2 |
Prior alcoholism inpatient treatments (n) | |
0 | 0 |
1 | 1 |
≥ 1 | 2 |
Table 3 Comorbidities associated with alcohol related liver disease
Cardiovascular | Alcoholic cardiomyopathy |
Cirrhotic cardiomyopathy | |
Coronary artery disease | |
Musculoskeletal | Myopathy |
Osteopenia | |
Neurologic | Wernicke-Korsakoff psychosis |
Alcoholic dementia | |
Alcoholic cerebellar degeneration | |
Peripheral neuropathy | |
Malnutrition | |
Chronic pancreatitis | |
Hepatocellular carcinoma | |
Hepatitis B or C infection | |
Other malignancy | Upper aerodigestive tract malignancy |
Psychiatric | Depression or mood disorders |
Personality disorders | |
Anxiety disorders | |
Psychosis |
Table 4 Outcome of post-orthotopic liver transplantation in patients with alcoholic liver disease, combined alcoholic liver disease with hepatitis C virus and hepatitis C virus alone n (%)
Study | ALD | ALD + HCV | HCV | Others |
Burra et al[76] | n = 9880 | n = 1119 | n = 6672 | |
Patient survival 1-yr, 3-yr, 5-yr, 10-yr | 84%, 78%, 73%, 58% | 84%, 75%, 65%, 52% | 81%, 72%, 67%,54% | |
Aguilera et al[77] | n = 107 | n = 60 | n = 170 | |
HCC | 19 (18) | 21 (35) | 75 (44) | |
Graft loss | 35 (33) | 25 (42) | 95 (56) | |
Severe recurrent HCV disease | 22/49 (45) | 54/122 (45) | ||
Retransplant | 4 (4) | 8 (13) | 7 (4) | |
De-novo tumors | 14/107 (13) | 2/67 (3) | 10/67 (6) | |
Rejection | 17/100 (17) | 9/60 (15) | 32/169 (19) | |
Patient survival 1-yr, 5-yr, 7-yr | 90%, 76%, 67% | 86%, 73%, 63% | 72%, 49%, 43% | |
Graft survival 1-yr, 5-yr, 7-yr | 89%, 76%, 67% | 83%, 63%, 56% | 71%, 48%, 43% | |
Mortality | 29 (27) | 21 (35) | 95 (56) | |
Cause of death | ||||
Recurrent disease | 3 (3) | 9 (15) | 44 (26) | |
Sepsis | 7 (6.5) | 7 (12) | 26 (15) | |
De-novo tumors | 9 (8) | 2 (3.5) | 6 (3.5) | |
Neuberger et al[4] | ||||
HCC (%) | 11 | 26 | 28 | |
Yamauchi et al[78] Yamanaka et al[79] | ||||
Risk of HCC (at 10-yr) | 15%-20% | 50%-80% | ||
Khan et al[80] | n = 14 | n = 24 | n = 40 | n = 42 |
HCV RNA (Meq/mL) | 2.3 ± 1.7 | 2.7 ± 2.9 | 2.3 ± 2.6 | |
Necroinflammation | 1.8 ± 0.7 | 3.1 ± 1.1 | 3.4 ± 1.6 | 2.9 ± 1.3 |
Fibrosis | 2.9 ± 1.0 | 3.6 ± 0.7 | 2.9 ± 0.9 | 3.4 ± 1.0 |
Cirrhosis | 5 (8.4) | 16 (27.2) | 10 (16.9) | 28 (47.5) |
HCC | 5 (9) | 14 (25.5) | 10 (18.2) | 26 (47.3) |
Size of HCC | 1.9 ± 0.8 | 2.5 ± 0.8 | 2.5 ± 1.0 | 2.4 ± 0.9 |
Donato et al[81] | ||||
Relative risk for HCC | 4.6 | 64.7 | 23.2 |
Table 5 Post-orthotopic liver transplantation events-rejection, infection, malignancy, retransplantation and cardiac events
Study | Rejection (%) | Infection (%) | Malignancy (%) | Retransplantation (%) | Cardiac events (%) | |||||
ALD | Non-ALD | ALD | Non-ALD | ALD | Non-ALD | ALD | Non-ALD | ALD + viral | Non-ALD | |
Burra et al[76] | 7.6 | 10.1 | 15.5 | 17.6 | 13.7/5.41 | 5.6/21 | 8 | 5.3 | ||
Pfitzmann et al[5] | 4.7-6.32 | 9.4-18.8/3.82 | 3-11.82 | |||||||
Wiesner et al[83] | Significantly less in ALD vs non-ALD | Bacteremia, overall fungemia, and CMV infection, comparable | De-novo tumors significantly increased in ALD vs non-ALD | 3 | 9 | |||||
Bhagat et al[84] | 23/23 | 41/43 | 432 | 53 | 292 | 0 | 3.6 | 5.6 | 72 | 26 |
Table 6 Comparison of outcomes of patients with alcoholic liver disease post-orthotopic liver transplantation
Study | Time period | Number of patients | Survival (%) | Relapse (%) any (abusive) | Death due to relapse (%) | |||
1-yr | 3-yr | 5-yr | 10-yr | |||||
Burra et al[76] | 1988-2005 | ALD-9880 | 84 | 78 | 73 | 58 | 33 (11) | 4.3 |
ALD + HCV-1119 | 84 | 75 | 65 | 52 | 18.3 | |||
ALD + HBV-309 | 89 | 85 | 81 | 64 | ||||
Cryptogenic-2410 | 78 | 73 | 69 | 61 | ||||
Bhagat et al[84] | 1997-2007 | ALD-83 | 92 | 86 | 86 | 761 | ||
NASH-71 | 82 | 79 | 75 | 621 | ||||
Gedaly et al[22] | 1995-2007 | ALD-147 | 96.2 | 89.6 | 84.4 | 19 | ||
Pfitzmann et al[5] | 1989-2002 | ALD-300 | 96 | 88 | 76 | 19 (8) | 4.8 | |
Non-ALD | 97 | 80 | 72 | |||||
OPTN/SRTR 2006[113] | 1996-2005 | All causes of cirrhosis | 86.9 | 82.4 | ||||
Lim et al[101] | 1988-1997 | ALD-3063 | 81.9 | 73.9 | 67.9 | 13 | ||
Viral hepatitis-4267 | 80.3 | 71.7 | 65.3 | |||||
Bellamy et al[82] | ALD-123 | 84 | 72 | 632 | 10 | |||
Mackie et al[110] | 1996-1999 | ALD-64 | 82 | 823 | 45.6 (6.5) | |||
Non-ALD-335 | 83 | 823 | ||||||
Gerhardt et al[114] | 1985-1991 | ALD-67 | 90 | 844 | 824 | 764 | 26 (4.8) | 4.5 |
Lucey et al[15] | 1985-1989 | ALD-45 | 78 | 733 | 4.4 | |||
Non-ALD-111 | 70 | 653 | ||||||
Kumar et al[115] | 1982-1988 | ALD-73 | 74 | 11.5 | 2 | |||
Non-ALD | 67 |
- Citation: Varma V, Webb K, Mirza DF. Liver transplantation for alcoholic liver disease. World J Gastroenterol 2010; 16(35): 4377-4393
- URL: https://www.wjgnet.com/1007-9327/full/v16/i35/4377.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i35.4377